Profile picture

Associate Professor Pietro Ameri

University of Genoa, Genova (Italy)
Membership: FESC Member HFA Member
Follow
Biography
Pietro Ameri is Associate Professor of Cardiovascular Diseases and Coordinator of the PhD Program in Translational and Clinica Internal Medicine at the University of Genova, Italy. He also leads the Translational Cardiovascular Unit and the cardio-oncology service at the affiliated hospital IRCCS Ospedale Policlinico San Martino. He is currently Secretary of the ESC Council of Cardio-oncology and has been chairperson of the first ESC Cardio-Oncology Conference. His primary interests are cardio-oncology and heart failure, including pulmonary hypertension. Pietro Ameri's research group includes biologists, biotechnologists and physicians and is funded by several grants. If he was asked where he would like to go again, now he would answer Dunmore Head, any trail in Liguria with a view of the sea, or the Hudson River Park
Logo ESC

Contributor content

Fireside Chat: cardio-oncology 2030 - what's next?
Session
Fireside Chat: cardio-oncology 2030 - what's next?
31 August 2026
Late-Breaking Clinical Science: cardio-oncology
Session
Late-Breaking Clinical Science: cardio-oncology
30 August 2026
Pulmonary hypertension: pathophysiology and mechanisms
Session
Pulmonary hypertension: pathophysiology and mechanisms
29 August 2026
Tumours of the heart: clinical insights and emerging evidence
Session
Tumours of the heart: clinical insights and emerging evidence
29 August 2026
Young Investigator Award - Clinical Cardiology
Session
Young Investigator Award - Clinical Cardiology
20 June 2026
Unmet needs in cardio-oncology: advancing the field together
Session
Unmet needs in cardio-oncology: advancing the field together
19 June 2026
Module E: industrial applications - Advanced models of drug testing for cardiac diseases
Session
Module E: industrial applications - Advanced models of drug testing for cardiac diseases
14 June 2026
Myocarditis: clinical course and management
Session
Myocarditis: clinical course and management
11 May 2026
Cancer therapy related cardiac dysfunction
Session
Cancer therapy related cardiac dysfunction
10 May 2026
Amyloidosis
Session
Amyloidosis
26 January 2026